Knee Range of Motion as a Discriminatory Tool Indicating Potential Meniscal Tears

膝关节活动范围作为鉴别诊断工具,可用于提示潜在的半月板撕裂

阅读:1

Abstract

BACKGROUND: Primary care physicians often encounter patients with knee pain and are faced with the dilemma of whether to refer patients to a specialist. Meniscal tears are the most common intraarticular knee injury but are challenging to accurately diagnose because of a lack of quantitative, accurate, and easy-to-administer tests. We conducted a retrospective medical record review to evaluate whether measurement of knee range of motion (ROM) via goniometry could discriminate between healthy and meniscus-altered knees. METHODS: A total of 110 adult patients met the inclusion criteria: age ≥18 years; no history of contralateral knee pain, injury, or surgery; ROM data collected using a goniometer on both knees at the time of diagnosis; and a confirmed diagnosis of meniscus tear via magnetic resonance imaging. The following variables were obtained from medical records: age, sex, body mass index (BMI), ROM for both knees, surgical treatment, insurance coverage, Ahlbäck x-ray grades, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the Oxford Knee Score (OKS). RESULTS: The majority of patients (96.4%) exhibited a ≥10° difference in flexion between asymptomatic and symptomatic knees. No significant relationships were observed between age, BMI, and the decision to undergo surgery and the difference in flexion or extension ROM. Both the WOMAC and the OKS were significantly correlated with the degree of loss of flexion ROM. CONCLUSION: The results suggest that knee flexion ROM may be a valuable tool for determining which patients presenting with new-onset ipsilateral knee pain should be referred to a specialist. Further investigation to determine the reliability and accuracy of knee ROM as a screening measure is warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。